v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
June 2025 [Member]
Common Stock
Common Stock
June 2025 [Member]
Additional Paid In Capital
Additional Paid In Capital
June 2025 [Member]
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2024 $ 835,619   $ 7   $ 1,591,707   $ (754,610) $ (1,485)
Shares, Outstanding, Beginning Balance at Dec. 31, 2024     64,890,193          
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance   $ 272,671       $ 272,671    
Issuance of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance cost, shares       5,899,500        
Issuance of shares under employee stock purchase plan, Shares     44,129          
Issuance of shares under employee stock purchase plan 1,112       1,112      
Exercise of stock options 12,789       12,789      
Exercise of stock options, Shares     629,222          
Vesting restricted stock, Shares     278,130          
Stock-based compensation expense 45,451       45,451      
Unrealized loss on marketable securities 2,986             2,986
Net loss (224,370)           (224,370)  
Ending Balance at Sep. 30, 2025 946,258   $ 7   1,923,730   (978,980) 1,501
Shares, Outstanding, Ending Balance at Sep. 30, 2025     71,741,174          
Beginning Balance at Jun. 30, 2025 971,480   $ 7   1,867,999   (896,805) 279
Shares, Outstanding, Beginning Balance at Jun. 30, 2025     70,557,442          
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance   $ 35,376       $ 35,376    
Issuance of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance cost, shares       855,000        
Exercise of stock options 4,553       4,553      
Exercise of stock options, Shares     275,484          
Vesting restricted stock, Shares     53,248          
Stock-based compensation expense 15,802       15,802      
Unrealized loss on marketable securities 1,222             1,222
Net loss (82,175)           (82,175)  
Ending Balance at Sep. 30, 2025 946,258   $ 7   1,923,730   (978,980) 1,501
Shares, Outstanding, Ending Balance at Sep. 30, 2025     71,741,174          
Beginning Balance at Dec. 31, 2025 1,579,664   $ 8   2,643,817   (1,065,961) 1,800
Shares, Outstanding, Beginning Balance at Dec. 31, 2025     81,323,532          
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance 215,393   $ 1   215,392      
Issuance of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance cost, shares     2,032,140          
Issuance of shares under employee stock purchase plan, Shares     25,952          
Issuance of shares under employee stock purchase plan 1,472       1,472      
Exercise of stock options 43,195       43,195      
Exercise of stock options, Shares     1,563,730          
Vesting restricted stock, Shares     380,149          
Stock-based compensation expense 53,782       53,782      
Unrealized loss on marketable securities (16,535)             (16,535)
Net loss (262,444)           (262,444)  
Ending Balance at Sep. 30, 2026 1,614,527   $ 9   2,957,658   (1,328,405) (14,735)
Shares, Outstanding, Ending Balance at Sep. 30, 2026     85,325,503          
Beginning Balance at Jun. 30, 2026 1,509,256   $ 8   2,712,811   (1,196,406) (7,157)
Shares, Outstanding, Beginning Balance at Jun. 30, 2026     82,788,253          
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance 215,393   $ 1   215,392      
Issuance of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance cost, shares     2,032,140          
Exercise of stock options 10,618       10,618      
Exercise of stock options, Shares     375,564          
Vesting restricted stock, Shares     129,546          
Stock-based compensation expense 18,837       18,837      
Unrealized loss on marketable securities (7,578)             (7,578)
Net loss (131,999)           (131,999)  
Ending Balance at Sep. 30, 2026 $ 1,614,527   $ 9   $ 2,957,658   $ (1,328,405) $ (14,735)
Shares, Outstanding, Ending Balance at Sep. 30, 2026     85,325,503